July 16, 2026 | Leslie Aquinde
GLP-1 Shows Promise for Patients with Advanced Fatty Liver DiseaseGLP-1 semaglutide shows improved liver scarring in advanced MASH, early cirrhosis, offering a potential new treatment option in a large global trial study.